davunetide

Related by string. Davunetide * * davunetide intranasal AL . candidate davunetide . davunetide intravenous AL . davunetide improves . drugs davunetide intranasal *

Related by context. All words. (Click for frequent words.) 70 Davunetide 66 Plicera 66 davunetide intranasal AL 65 methylnaltrexone 65 PD LID 64 Safinamide 64 ProSavin 64 GAMMAGARD 64 Rasagiline 64 tramiprosate 63 tafamidis 63 Pimavanserin 63 Pirfenidone 63 Panzem 63 Xanafide 63 Phenoptin 63 SNT MC# 63 Catena ® 63 YONDELIS 63 IRX 2 63 Tasimelteon 63 mGluR2 NAM 63 tocilizumab 63 amrubicin 63 Orphan Drug designation 63 INCB# [001] 62 EGS# 62 alvimopan 62 Orazol 62 TREANDA 62 Golimumab 62 Genz # 62 Zerenex 62 Ocrelizumab 62 diabetic neuropathic pain 62 Archexin 62 Azedra 62 Posiphen 62 AZILECT R 62 R#/MEM # 62 beta 1a 62 Fibrillex TM 62 Firazyr 62 ATL# [001] 62 relapsing remitting multiple sclerosis 61 Traficet EN 61 eltrombopag 61 vidofludimus 61 EndoTAG TM -1 61 Phenserine 61 Cinryze ™ 61 Bicifadine 61 Evoltra ® 61 canakinumab 61 PEG SN# 61 Neurodex 61 ATL/TV# 61 Marqibo 61 Phase IIB 61 #D#C# 61 atacicept 61 riociguat 61 Amrubicin 61 laquinimod 61 Rebif ® 61 LY# [003] 61 dirucotide 61 IMA# 61 PBT2 61 ospemifene 61 Everolimus 61 teriflunomide 61 KRN# 61 Triolex 61 Prestara 61 Dacogen injection 61 TELINTRA 61 OHR/AVR# 61 Desmoteplase 61 IL# PE#QQR 61 PCK# 61 RhuDex 61 orBec 61 elotuzumab 61 vascular disrupting agent 61 BNC# 61 PXD# 61 ALN TTR 60 Lu AA# 60 Huntexil 60 oral prodrug 60 metaglidasen 60 MBP# [001] 60 PREOS 60 HuLuc# 60 Tyrima 60 FTY# 60 synthetic retinoid 60 Torisel 60 tauopathies 60 CTAP# Capsules 60 Vilazodone 60 safinamide 60 Valortim ® 60 schizophrenia CIAS 60 multiple myeloma MM 60 Onconase 60 mGlu2 3 60 candidate davunetide 60 tanespimycin 60 R roscovitine 60 R#/MEM 60 rilonacept 60 Kuvan 60 #ME# 60 Androxal TM 60 Phase IIa clinical 60 Tamibarotene 60 Epratuzumab 60 UPLYSO 60 JAK inhibitor 60 HuMax CD4 60 AeroLEF TM 60 lurasidone 60 pomalidomide 60 Romiplostim 60 SGS# 60 Meets Primary Endpoint 60 DR Cysteamine 60 IRESSA 60 placebo controlled clinical 60 CEQ# 60 Symadex 60 Bezielle 60 Civacir 60 CIMZIA ™ 60 registrational trial 60 NV1FGF 60 PLK1 SNALP 60 maribavir 60 FOLOTYN ® 60 cilengitide 60 baminercept 60 MAA submission 60 Iloperidone 60 ancrod 60 DXL# 60 neuroprotective properties 60 Aviptadil 60 mipomersen 60 pseudobulbar affect PBA 60 milatuzumab 60 phase IIb clinical 60 Behcet uveitis 60 selective androgen receptor modulator 60 refractory gout 60 liposomal formulation 60 acetonide FA 60 Phase IIIb clinical 60 anticancer agent 60 Virulizin ® 60 RSR# 60 RDEA# 60 Pivotal Phase III 60 rasagiline tablets 59 Relivar 59 proteasome inhibitor 59 Phase Ib study 59 Phase Ib clinical 59 lumiliximab 59 sorafenib tablets 59 Icatibant 59 Removab 59 tramiprosate ALZHEMED TM 59 Campath alemtuzumab 59 orphan medicinal product 59 selective modulator 59 phase IIa clinical 59 Bortezomib 59 ELND# 59 Miraxion 59 ocrelizumab 59 efalizumab 59 anticancer compound 59 glufosfamide 59 Ophena TM 59 Mipomersen 59 TH# [003] 59 ARIKACE ™ 59 KNS # 59 Vernakalant 59 lorvotuzumab mertansine 59 Valdoxan 59 Raptiva ® 59 RhuDex ® 59 OMP designation 59 rFVIIIFc 59 SRT# [003] 59 TG# [003] 59 ISIS # 59 Microplasmin 59 ataluren 59 IMiDs 59 TEMODAL 59 targeted radiotherapeutic 59 Nuvion 59 custirsen 59 Laquinimod 59 cannabinor 59 Fx #A 59 Diamyd ® 59 rotigotine 59 Ceflatonin 59 bosentan 59 Ostarine 59 icatibant 59 Daclizumab 59 oral FTY# 59 ONCONASE R 59 TBC# 59 Aflibercept 59 otelixizumab 59 Personalized Immunotherapy 59 PROVENGE ® 59 HuMax EGFr 59 Alemtuzumab 59 romidepsin 59 ularitide 59 Octreolin 59 EOquin TM 59 Cogane 59 blinatumomab 59 Natalizumab 59 Serdaxin 59 Pemetrexed 59 TACI Ig 59 Tanespimycin 59 dimebon 59 Fast Track Status 59 fibrotic disease 59 Alzheimer disease cognitive impairment 59 PROMACTA 59 ACZ# 59 Arimoclomol 59 tiapamil 59 Glufosfamide 59 neurotrophic factor 59 Alzhemed TM 59 TYSABRI natalizumab 59 confirmatory Phase III 59 Vectibix panitumumab 59 Ambrisentan 59 diabetic macular edema DME 59 diarrhea predominant irritable 59 ALN PCS 59 zileuton 59 XmAb# 59 Panzem R 59 virus HCV protease inhibitor 59 Aryplase 59 DCCR 59 postoperative ileus 59 PDE4 inhibitor 59 forodesine 59 HQK 59 Pazopanib 59 anti amnesic 58 sipuleucel T 58 Betaferon ® 58 sargramostim 58 Alzhemed 58 novel oral anticoagulant 58 MAXY G# 58 NOXAFIL 58 ADAGIO study 58 CBLC# 58 EVIZON 58 alvespimycin 58 aclidinium bromide 58 ZYBRESTAT 58 ocular formulation 58 CORT # 58 Dasatinib 58 Vidofludimus 58 Fasudil 58 denufosol 58 Dapagliflozin 58 Diabetic Macular Edema 58 Pivotal Phase 58 JAK inhibitors 58 favorable pharmacokinetic profile 58 tau pathology 58 preclinically 58 Arcalyst 58 MYDICAR ® 58 ibudilast 58 eniluracil 58 cholinesterase inhibitors 58 preclinical efficacy 58 Cimzia ® certolizumab pegol 58 candidate Zenvia 58 Teriflunomide 58 OvaRex ® MAb 58 CYT# potent vascular disrupting 58 orphan designation 58 BRIM3 58 mGluR5 NAM 58 MAXY VII 58 TRIOLEX 58 AZILECT ® 58 systemically administered 58 Aplidin 58 Orphan Status 58 torezolid phosphate 58 bardoxolone methyl 58 antidepressant efficacy 58 Cethromycin 58 MGd 58 Onalta 58 thymalfasin 58 Troxatyl 58 NGX# 58 ThGRF 58 Dalbavancin 58 Ilaris 58 Preclinical studies suggest 58 INCB# [002] 58 Orphan Drug status 58 CoFactor 58 generation purine nucleoside 58 NUVIGIL 58 histone deacetylase HDAC inhibitor 58 Elocalcitol 58 nitazoxanide 58 oral ridaforolimus 58 Clofarabine 58 Squalamine 58 Insegia 58 relapsing multiple sclerosis 58 ZOLINZA 58 Preclinical studies 58 LibiGel ® 58 Syncria 58 Vandetanib 58 investigational compound 58 Phase IIb clinical 58 Orphan Designation 58 pharmacokinetic PK study 58 guanfacine extended release 58 Etanercept 58 Amigal 58 investigational atypical antipsychotic 58 lomitapide 58 Tavocept 58 reslizumab 58 tasocitinib 58 AAG geldanamycin analog 58 ofatumumab 58 axitinib 58 donepezil 58 orally bioavailable 58 HuMax CD# 58 CORLUX 58 HGS ETR1 58 antitumor effects 58 castration resistant prostate cancer 58 desvenlafaxine 58 vilazodone 58 depsipeptide 58 Valortim R 58 opioid induced constipation 58 Nexavar ® 58 compound INCB# 58 6R BH4 58 pirfenidone 58 Cetrorelix 58 immune modulatory 58 Interferon beta 58 Alvesco R 58 DPP4 58 Prodarsan ® 58 anti EGFR antibody 58 oral methylnaltrexone 58 Clinical Trial Results 58 Tezampanel 58 CB1 antagonists 58 Friedreich Ataxia FRDA 58 Iluvien ® 57 LymphoStat B 57 CDP# 57 CINQUIL 57 TMC# [002] 57 neuroprotective 57 Telintra 57 novel VDA molecule 57 teduglutide 57 Reverset 57 palonosetron 57 HCV protease inhibitors 57 dirucotide MBP# 57 Factor VIIa 57 NLX P# 57 APOPTONE 57 Nanobody ® 57 Sym# 57 rindopepimut 57 Zoraxel 57 lucinactant 57 Phase 2a clinical 57 Nexavar sorafenib 57 R sorafenib tablets 57 Azixa 57 Octreotide 57 PEGylated interferon beta 1a 57 mertansine 57 Zavesca r 57 RoACTEMRA 57 Soliris TM eculizumab 57 Cethrin 57 vorinostat 57 QNEXA 57 pan HDAC inhibitor 57 velafermin 57 Omapro 57 Aurexis 57 Dyloject TM 57 GALNS 57 SAR# [004] 57 MAGE A3 ASCI 57 prucalopride 57 zanolimumab 57 Lubiprostone 57 desvenlafaxine succinate 57 Virulizin R 57 Ceflatonin R 57 eprotirome 57 CR# vcMMAE 57 OXi# 57 Elagolix 57 Fabry Disease 57 Advagraf 57 iSONEP 57 midstage trials 57 Arranon 57 EDEMA3 57 paliperidone palmitate 57 immune modulator 57 OncoVEX GM CSF 57 PREOS R 57 PEG PAL 57 humanized anti 57 PROSTVAC TM 57 LHRH antagonists 57 trabedersen 57 phase IIb trial 57 AEG# 57 LAF# 57 NP2 Enkephalin 57 palifermin 57 refractory chronic lymphocytic 57 targeting CD# 57 NVA# 57 liprotamase 57 dyskinesia PD LID 57 Zalbin 57 SomatoKine 57 Egrifta 57 Rotigotine 57 PSMA ADC 57 sitaxsentan 57 Corlux 57 lintuzumab SGN 57 mGluR2 57 receptor inhibitor 57 Lenocta 57 Serdolect ® 57 Annamycin 57 Maribavir 57 Tolvaptan 57 receptor tyrosine kinase inhibitor 57 Restanza 57 Rilonacept 57 Ofatumumab 57 recurrent glioblastoma multiforme 57 Santhera 57 Interferon alpha 57 SUTENT ® 57 Halaven 57 ON #.Na 57 vismodegib 57 BAY #-# 57 erlotinib Tarceva 57 MGCD# [001] 57 Romidepsin 57 clobazam 57 menadione 57 Entereg TM 57 aMCI precursor 57 Severe Sepsis 57 investigational humanized monoclonal antibody 57 subcutaneous formulation 57 Omacetaxine 57 LY# [002] 57 Zebinix R 57 MyVax R 57 IL #E 57 ATryn R 57 BCX# 57 hepatic encephalopathy 57 Diamyd R 57 rufinamide 57 interferon beta 1b 57 DDP# 57 febuxostat 57 Mirapexin 57 YONDELIS R 57 gefitinib Iressa 57 sapropterin dihydrochloride 57 Fodosine 57 ASONEP 57 Phase IIb trials 57 Onco TCS 57 iloperidone 57 obatoclax 57 lymphoma CTCL 57 Pafuramidine 57 Pradefovir 57 Oral NKTR 57 PRTX 57 Neupro R 57 tezampanel 57 omacetaxine mepesuccinate 57 EndoTAGTM 1 57 enzastaurin 57 Donepezil 57 Apoptone 57 biologic therapy 57 CD# monoclonal antibody 57 indibulin 57 CIMZIA TM 57 squalamine 57 inhibit metastasis 57 brivaracetam 57 CIPN 57 A3 adenosine receptor 57 GLP1 agonist 57 LymphoStat B belimumab 57 cutaneous T cell 57 Systemic Juvenile Idiopathic 57 Campath ® 57 Onbrez Breezhaler 57 Febuxostat 57 orally inhaled migraine 57 DPX Survivac 57 Voreloxin 57 zileuton CR 57 goserelin 57 asenapine 57 Myelodysplastic Syndrome MDS 57 TOCOSOL Paclitaxel 57 Pyridorin 57 sorafenib Nexavar 57 Pixantrone 57 TriRima 57 Irinotecan 57 elagolix 57 opioid induced bowel dysfunction 57 MNTX 57 PRT# 57 PNP inhibitor 57 Phase 2b trial 57 PHX# 57 Homspera TM 57 Generx 57 regorafenib 57 AKT inhibitor 57 L BLP# 57 Zybrestat 57 Keppra XR 57 myeloproliferative diseases 57 Phase 2a trial 57 NeuroVax TM 57 #I TM# 57 myelofibrosis 57 BENLYSTA ® 57 epigenetic therapies 56 lixisenatide 56 ORENCIA R 56 chronic lymphocytic leukemia CLL 56 fosbretabulin 56 QRxPharma 56 eprodisate Fibrillex TM 56 rFIXFc 56 tezampanel NGX# 56 dexanabinol 56 ELACYT 56 intranasal formulation 56 Lamotrigine 56 Promacta 56 Zenvia ™ 56 Allovectin 7 R 56 LIALDA 56 midstage clinical 56 Increlex ® 56 Bifeprunox 56 prokinetic agent 56 decitabine 56 refractory CLL 56 TNF Tumor Necrosis Factor 56 aclidinium 56 tetrabenazine 56 GW# [003] 56 Orphan Drug designations 56 lintuzumab 56 MACUGEN 56 volociximab 56 gabapentin enacarbil 56 BRIM2 56 Clonicel 56 Granted Orphan Drug 56 EndoTAG TM 56 AA amyloidosis 56 Somatuline Depot 56 small molecule Hedgehog 56 Genentech Rituxan 56 picoplatin 56 visilizumab 56 nonclinical studies 56 Chrysalin 56 Cotara 56 TKM ApoB 56 Satraplatin 56 pharmacological chaperone 56 ACAPODENE 56 prGCD 56 HspE7 56 Cloretazine ® 56 ENMD # 56 investigational therapies 56 ganaxolone 56 Stedivaze 56 Tarceva TM 56 Tarceva erlotinib 56 Orphan Drug Status 56 Gabapentin GR 56 CGEN # 56 angiogenesis inhibitor 56 Xinlay 56 OMS#HP 56 daclizumab 56 oral rivaroxaban 56 Numax 56 placebo controlled Phase 56 Darinaparsin 56 histamine dihydrochloride 56 Abatacept 56 ozarelix 56 cell lymphoma CTCL 56 anti CD3 antibody 56 Tocilizumab 56 Lupuzor 56 phase 2a 56 relapsing forms 56 non metastatic osteosarcoma 56 Afatinib 56 ZYBRESTAT fosbretabulin 56 Theratope 56 Phase 2a 56 MORAb 56 idiopathic pulmonary fibrosis IPF 56 PEG Interferon lambda 56 Azilect 56 relapsed MM 56 ambrisentan 56 Lacosamide 56 EVIZON TM 56 Perforomist ™ Inhalation Solution 56 fingolimod 56 ACOMPLIA R 56 MELAS 56 subcutaneously administered 56 Enzyme Replacement Therapy 56 mTOR inhibitor 56 bapineuzumab 56 mifamurtide 56 Onrigin 56 AzaSite Plus 56 Azilect ® 56 Luteinizing Hormone Releasing Hormone 56 ramelteon 56 synthetic siRNA 56 Unit Dose Budesonide 56 OMAPRO 56 evaluating tivozanib 56 dexpramipexole 56 aleglitazar 56 Liraglutide 56 temsirolimus 56 ONGLYZA ™ 56 progressive supranuclear palsy 56 2A receptor agonist 56 tipranavir 56 TLR9 agonists 56 gastrointestinal stromal tumors 56 albinterferon alfa 2b 56 Rezular 56 sapacitabine 56 Targretin capsules 56 vildagliptin 56 pediatric Crohn disease 56 TRAIL induced apoptosis 56 incyclinide 56 AGILECT R 56 GRALISE 56 GRN#L 56 Actimmune ® 56 Cladribine Tablets 56 neuroprotective effects 56 tasimelteon 56 Emselex 56 lupus nephritis 56 mGluR2 positive 56 pralatrexate 56 Exelixis compounds 56 perampanel 56 CXB# 56 Viprinex TM 56 Benlysta belimumab 56 Abiraterone acetate 56 Evoltra 56 oral cladribine 56 Triapine 56 DPP4 inhibitor 56 bifeprunox 56 Virulizin 56 investigational monoclonal antibody 56 docetaxel chemotherapy 56 mapatumumab 56 vosaroxin 56 hyperphenylalaninemia HPA due 56 EGFr 56 Avanafil 56 Herceptin trastuzumab 56 therapeutic monoclonal antibody 56 DACH platinum 56 Vimpat R 56 panitumumab Vectibix 56 bicifadine 56 BRAF inhibitor 56 ZADAXIN ® 56 VPRIV 56 pegylated 56 octreotide implant 56 antiangiogenic 56 Fingolimod 56 MoxDuo IR 56 Aclidinium 56 orally administered inhibitor 56 DexaSite 56 Advexin 56 oral nucleoside analogue 56 solanezumab 56 MAP# 56 Hedgehog Pathway Inhibitor 56 Allovectin 7 56 Viprinex 56 post menopausal osteoporosis 56 Revlimid lenalidomide 56 Topiramate 56 Imprime PGG 56 RGB # 56 oxymorphone ER 56 phase IIa 56 MBP# dirucotide 56 Avastin bevacizumab 56 PRX # 56 DU #b 56 hematological cancers 56 quetiapine fumarate 56 Seliciclib 56 TYZEKA 56 GSK# [001] 56 dextromethorphan quinidine 56 HoFH 56 pharmacodynamic properties 56 NEBIDO 56 bortezomib Velcade 56 ADVEXIN 56 HSP# inhibitor 56 post herpetic neuralgia PHN 56 unoprostone isopropyl 56 interferon gamma 1b 56 Panzem R NCD 56 RAPTIVA 56 Certican 56 Synavive 56 alemtuzumab 56 Atrasentan 56 Adalimumab 56 non nucleoside inhibitor 56 PS# [001] 56 leukemia ALL 56 ONTAK 56 Temsirolimus 56 Targretin 56 Degarelix 56 Gleevec imatinib mesylate 56 REMINYL ® 56 bardoxolone 56 triglyceride lowering 56 ruxolitinib 56 somatostatin analog 56 Kepivance 56 ACTEMRA 55 Vidaza azacitidine 55 AEGR 55 CD# antibody [001] 55 XERECEPT R 55 CA4P 55 octreotide acetate 55 Carfilzomib 55 interferon beta 55 Preos 55 Perifosine 55 HGS# 55 fulvestrant 55 rasagiline 55 COPAXONE ® 55 BiovaxID TM 55 Zorbtive TM 55 Bafetinib 55 antisense drug 55 Ketotransdel 55 Adentri 55 leukemia AML 55 Intervention Effectiveness 55 GRAZAX R 55 SILENOR TM 55 adalimumab Humira 55 PEGylated Fab fragment 55 Nabi HB Intravenous 55 TMC# [001] 55 Riquent 55 RLY# 55 Neuradiab 55 vandetanib 55 lubiprostone 55 Serdolect 55 Fast Track Designation 55 cortical stimulation 55 VAPRISOL 55 Cimzia 55 iniparib 55 memantine HCl 55 satraplatin 55 EFAPROXYN 55 Neupro 55 alefacept 55 CONBRIZA 55 bendamustine 55 Dimebon 55 deforolimus 55 Ranolazine 55 incretin 55 Fampridine SR 55 Cinquil 55 Clolar ® 55 Bevacizumab 55 agomelatine 55 terlipressin 55 rotigotine transdermal patch 55 Amplimexon 55 arzoxifene 55 BZL# 55 Talabostat 55 gamma secretase inhibitor 55 azacitidine 55 ALKS 55 elacytarabine 55 Junovan 55 Initiates Phase III 55 Orphan Drug Designation 55 interferon beta 1a 55 HCV protease 55 primary hypercholesterolemia 55 Esbriet ® 55 Anidulafungin 55 Azacitidine 55 PPAR gamma agonists 55 polymerase inhibitor 55 Pertuzumab 55 long acting muscarinic 55 rHuPH# 55 maximally tolerated dose 55 Phase IIa trial 55 FTY# fingolimod 55 dasatinib 55 MultiStem 55 CYT# 55 disease modifying 55 Abilify aripiprazole 55 subependymal giant cell 55 somatostatin analogue 55 Soliris eculizumab 55 INCB# [003] 55 secondary hyperparathyroidism 55 Noxafil 55 GSK# [002] 55 nicotinic alpha 7 55 induced macular edema 55 calcineurin inhibitor 55 omacetaxine 55 viral kinetics 55 Arikace 55 RRMS patients 55 Proxinium TM 55 Fibrillex 55 Gleevec resistant 55 miglustat 55 Oracea TM 55 talactoferrin 55 pramipexole 55 atrasentan 55 linaclotide 55 ORENCIA ® 55 Pathway Inhibitor 55 IBS C 55 CDK inhibitor 55 Increlex R 55 Entereg R 55 Dabigatran etexilate 55 lacosamide 55 Varespladib 55 Protelos 55 AP# [003] 55 Betaseron ® 55 DAVANAT ® 55 SinuNase TM 55 ISENTRESS raltegravir 55 donepezil Aricept 55 Janus kinase 55 LHON 55 KIACTA ™ 55 NNR Therapeutics 55 MEK inhibitor 55 bexarotene 55 Teriparatide 55 GATTEX 55 rhThrombin 55 TORISEL 55 SinuNase 55 Mycograb 55 IAP inhibitors 55 Gefitinib 55 perifosine 55 colesevelam HCl 55 Clavis Pharma 55 eculizumab 55 Sapacitabine 55 radezolid 55 GTC recombinant human 55 tecarfarin 55 Zenvia 55 ILUVIEN ® 55 Cloretazine R 55 ASA# 55 Bapineuzumab 55 KAPVAY ™ 55 Ciclesonide 55 tolevamer 55 elvucitabine 55 mitogen activated ERK kinase 55 investigational drug 55 AGILECT ® 55 Levadex 55 QNEXA ® 55 imetelstat 55 Eribulin 55 Pralatrexate 55 NexACT ® 55 DAVANAT R 55 motavizumab 55 Cladribine 55 mecamylamine 55 formerly LymphoStat B 55 cutaneous T 55 cancer cachexia 55 PF # [001] 55 Atiprimod 55 immunomodulatory 55 sunitinib malate 55 sodium glucose cotransporter 55 SUVN 55 celgosivir 55 cathepsin K inhibitor 55 paliperidone ER 55 MPS VI 55 relapsed multiple myeloma 55 Jevtana

Back to home page